Plastomics, Inc. Competitors

Greenhouse is the Orchestrated Hiring Ecosystem, bringing employers and job seekers together in one place to make hiring work for everyone in the AI era. Thousands of companies, including Anthropic, HubSpot, and the NFL, run their hiring on Greenhouse, and millions of job seekers use MyGreenhouse to share their full professional story. Greenhouse connects sourcing, interviewing, scheduling, and the applicant tracking system in a single hiring ecosystem, with products such as Voice AI, Real Talent, and Dream Job. Orchestration runs on signal, not applications: who is real, who is looking now, and why they might be right for the role, with people accountable for every hiring decision. Consistently recognized as an industry leader, Greenhouse has earned recent honors including G2’s 2026 Best HR Software Products, Best Software Products, Global Software Companies, and Highest Satisfaction Products lists, as well as TIME’s Best Inventions of 2025 for Dream Job and HR Executive’s 2026 Top HR Products for Real Talent. The company has been named to Fortune Best Workplaces, Inc. Best Workplaces, Glassdoor’s Best Places to Work, Forbes Cloud 100, Deloitte Technology Fast 500, Crain’s Best Places to Work NYC, and Mogul’s Top 100 Workplaces for Diverse Representation. For media inquiries, logos, and images, contact press@greenhouse.io.

Indigo Ag improves farmer profitability, environmental sustainability, and consumer health through the use of nature-based and digital technologies. The company’s core solutions – Sustainability and Biologicals – integrate across the supply chain to optimize how the world’s most impactful crops are produced, sourced, and distributed. Founded in 2013 with a mission of harnessing nature to help farmers sustainably feed the planet, today the company's technology connects stakeholders across the agricultural ecosystem to unlock sustainability and profitability benefits for all.

Cellectis is a global, clinical-stage biopharmaceutical company. As pioneers and innovators in our field, we are driven by a single mission: to develop breakthrough treatments for patients with unmet medical needs. With 26 years of expertise, we operate a best-in-class genome editing platform focused on immuno-oncology and gene therapy. By leveraging our proprietary gene-editing technologies, we engineer allogeneic CAR-T cells designed to recognize and eliminate cancer cells. Currently, our two lead clinical programs are evaluating therapies for B-cell acute lymphoblastic leukemia (B-ALL) and non-Hodgkin lymphoma (NHL). As a fully integrated leader in genome editing and allogeneic CAR-T cell research, we maintain complete end-to-end control over our manufacturing process. This vertical integration ensures quality across the board: • Paris, France: Production of starting materials • Raleigh, NC (USA): Manufacturing of the finished CAR-T products We have established powerful collaborations with industry leaders, including AstraZeneca and Allogene Therapeutics, to accelerate the development of product candidates across oncology, immunology, and rare diseases. Cellectis headquarters are in Paris, France, with additional locations in New York, New York and Raleigh, North Carolina. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). To find out more about us, visit our website: www.cellectis.com. To learn more about our community guidelines, visit: http://www.cellectis.com/en/social-media-guidelines/ Follow our other social media account on X. TALEN® is a registered trademark owned by the Cellectis Group.